Journal of the Korea Convergence Society (한국융합학회논문지)

Korea Convergence Society (한국융합학회)
권호 표지
DOI QR코드

DOI QR Code

Relationship between Body Mass Index and Insulin Resistance and Beta Cell Function by Obesity Type in Obese Middle-Aged Men

비만 중년 남성의 비만 유형별 체질량지수와 인슐린저항성 및 베타세포 기능간의 관련성

  • Shin, Kyung-A (Dept. of Clinical Laboratory Science, Shinsung University)
  • Received : 2020.08.06
  • Accepted : 2020.10.20
  • Published : 2020.10.28
Download PDF
⟨ Previous Next ⟩

Abstract

This study wanted to confirm the relevance between body mass index(BMI) and insulin resistance and beta-cell function based on abdominal obesity in obese middle-aged men. This study targeted 797 obese middle-aged men who had undergone health checkups at general hospitals in Gyeonggi-do from January 2018 to June 2020. There were 327 in the group with abdominal obesity and 470 in the group without abdominal obesity. Glucose(p<0.001), HbA1c(p=0.003), insulin(p<0.001), HOMA-IR(p<0.001) was different between groups. BMI was a factor affecting insulin resistance and beta cell function regardless of the with or without of abdominal obesity. BMI was associated with the onset of disease of insulin resistance and beta cell functional degradation regardless of the with or without of abdominal obesity. Therefore, it is considered necessary to manage the indicators of the BMI through exercise programs and regular checkups for health management of middle-aged obese men.

이 연구는 비만 중년 남성을 대상으로 복부비만 유무에 따른 체질량지수와 인슐린저항성 및 베타세포 기능간의 관련성을 알아보고자 하였다. 2018년 1월부터 2020년 6월까지 경기도 소재 종합병원에서 건강검진을 받은 비만 중년 남성 797명을 대상으로 하였다. 복부비만 동반군은 327명, 복부비만을 동반하지 않은군은 470명이며, 두 군간에 공복혈당(p<0.001), HbA1c(p=0.003), 인슐린(p<0.001), HOMA-IR(p<0.001)은 차이가 있었다. 체질량지수는 복부비만 동반 유무와 관계없이 인슐린저항성 및 베타세포 기능에 영향을 미치는 요인이었다. 또한 체질량지수는 복부비만 동반 유무와 관계없이 인슐린저항성 및 베타세포 기능저하의 질환 발병과 관련이 있었다. 따라서 중년 비만 남성의 건강관리를 위한 운동 프로그램 수행 및 정기적인 검진을 통해 체질량지수의 지표 관리가 필요할 것으로 사료된다.

Keywords

References

  1. P. Abelson & D. Kennedy. (2004). The obesity epidemic. Science, 304(5676), 1413. DOI: 10.1126/science.304.5676.1413
  2. P. T. James, R. Leach, E. Kalamara & M. Shayeghi. (2001). The worldwide obesity epidemic. Obesity Research, 9(Suppl 4), 228S-233S. DOI: 10.1038/oby.2001.123
  3. F. X. Pi-Sunyer. (1999). Comorbidities of overweight and obesity: current evidence and research issues. Medicine & Science in Sports & Exercise, 31(11 Suppl), 602-608. DOI: 10.1097/00005768-199911001-00019
  4. F. X. Pi-Sunyer. (1993). Medical hazards of obesity. Annals of Internal Medicine, 119(7 Pt 2), 655-660. DOI: 10.7326/0003-4819-119-7_part_2-199310011-00006
  5. P. W. Wilson, R. B. D'Agostino, L. Sullivan, H. Parise & W. B. Kannel. (2002). Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of internal medicine, 162(16), 1867-1872. DOI: 10.1001/archinte.162.16.1867
  6. R. M. Krauss, M. Winston, R. N. Fletcher & S. M. Grundy. (1998). Obesity: impact of cardiovascular disease. Circulation, 98(14), 1472-1476. DOI: https://doi.org/10.1161/01.cir.98.14.1472
  7. T. L. Visscher & J. C. Seidell. (2001). The public health impact of obesity. Annual Review of Public Health, 22, 355-375. DOI: 10.1146/annurev.publhealth.22.1.355
  8. T. Okura et al. (2018). Body mass index ${\geq}$23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report. Public Library of Science One, 13(7), e0201052. DOI: 10.1371/journal.pone.0201052
  9. P. Poirier et al. (2006). Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 113(6), 898-918. DOI: 10.1161/CIRCULATIONAHA.106.171016
  10. G. A. Colditz et al. (1990). Weight as a risk factor for clinical diabetes in women. American Journal of Epidemiology, 132(3), 501-513. DOI: 10.1093/oxfordjournals.aje.a115686
  11. G. H. Brody, T. Yu, E. Chen, K. B. Ehrlich & G. E. Miller. (2018). Racial discrimination, body mass index, and insulin resistance: A longitudinal analysis. Health Psychology, 37(12), 1107-1114. DOI: 10.1037/hea0000674
  12. K. Ah Kim & M. S. Lee. (2010). Role and mechanism of pancreatic $\beta$-cell death in diabetes: The emerging role of autophagy. Journal of Diabetes Investigation, 1(6), 232-238. DOI: 10.1111/j.2040-1124.2010.00054.x
  13. M. Kasuga. (2006). Insulin resistance and pancreatic beta cell failure. Journal of Clinical Investigation, 116(7), 1756-1760. DOI: 10.1172/JCI29189
  14. L. Mu, Y. Zhao, Y. Lai, R. Li & J. Qiao. (2018). Insulin resistance and $\beta$-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome. Clinical Endocrinology (Oxford), 89(6), 779-788. DOI: 10.1111/cen.13832
  15. E Ferrannini. (1998). Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocrine Reviews, 19(4), 477-490. DOI: 10.1210/edrv.19.4.0336
  16. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher & R. C. Turner. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. DOI: 10.1007/BF00280883
  17. J. O. Chung, D. H. Cho, D. J. Chung & M. Y. Chung. (2012). Associations among body mass index, insulin resistance, and pancreatic $\beta$-cell function in Korean patients with new-onset type 2 diabetes. Korean Journal of Internal Medicine, 27(1), 66-71. DOI: 10.3904/kjim.2012.27.1.66
  18. M. G. Park et al. (2016). The relationship between body mass index and homeostasis model assessment index and the impact of vitamin D: based on 2010 Korean National Health and Nutrition Survey. Korean Journal of Family Practice, 6(5), 457-463. DOI: 10.21215/kjfp.2016.6.5.457
  19. D. A. Garca-Estevez, D. Araujo-Vilar, A. Saavedra-Gonzalez, G. Fiestras-Janeiro & J. Cabezas-Cerrato. (2004). Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model. Metabolism, 53(11), 1462-1466. DOI: 10.1016/j.metabol.2004.06.014
  20. E. J. Rhee et al. (2018). Association between abdominal obesity and increased risk for the development of hypertension regardless of physical activity: A nationwide population-based study. Journal of Clinical Hypertension (Greenwich), 20(10), 1417-1426. DOI: 10.1111/jch.13389
  21. A. Pascot et al. (2000). Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Diabetologia, 43(9), 1126-1135. DOI: 10.1007/s001250051503
  22. A. Rodriguez-Campello et al. (2017). Sex-related differences in abdominal obesity impact on ischemic stroke risk. European Journal of Neurology, 24(2), 397-403. DOI: 10.1111/ene.13216
  23. F. W. Booth, S. E. Gordon, C. J. Carlson & M. T. Hamilton. (2000). Waging war on modern chronic diseases: primary prevention through exercise biology. Journal of Applied Physiology, 88(2), 774-787. DOI: 10.1152/jappl.2000.88.2.774
  24. World Health Organization. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney : Health Communications Australia.
  25. S. Lee et al. (2006). Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. Journal of Korean Medical Science, 21(4), 695-700. DOI: 10.3346/jkms.2006.21.4.695
  26. Y. Song et al. (2007). Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the women's health initiative observational study. Diabetes Care, 30(7), 1747-1752. DOI: 10.2337/dc07-0358
  27. R. C. Bonadonna & R. A. De Fronzo. (1991). Glucose metabolism in obesity and type 2 diabetes. Diabetes and Metabolism, 17(1 Pt 2), 112-135.
  28. G. Chen et al. (2010). Overweight, obesity, and their associations with insulin resistance and $\beta$-cell function among Chinese: a cross-sectional study in China. Metabolism, 59(12), 1823-1832. DOI: 10.1016/j.metabol.2010.06.009
  29. B. G. Baez-Duarte et al. (2010). $\beta$-cell function is associated with metabolic syndrome in Mexican subjects. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 3, 301-309. DOI: 10.2147/DMSOTT.S12375
  30. L. X. Cubeddu & I. S. Hoffmann. (2012). Impact of traits of metabolic syndrome on $\beta$-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects. Metabolic Syndrome and Related Disorders, 10(5), 344-350. DOI: 10.1089/met.2012.0040
  31. D. T. Finegood, I. M. Hramiak & J. Dupre. (1990). A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism, 70(6), 1538-1549. DOI: 10.1210/jcem-70-6-1538
  32. M. P. Hermans, J. C. Levy, R. J. Morris & R. C. Turner. (1999). Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes, 48(9), 1779-1786. DOI: 10.2337/diabetes.48.9.1779
  33. Q. Qiao & R. Nyamdorj. (2010). Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index? European Journal of Clinical Nutrition, 64(1), 30-34. DOI: 10.1038/ejcn.2009.93
  34. E. J. Sung, S. Sunwoo, S. W. Kim & Y. S. Kim. (2001). Obesity as a risk factor for non-insulin-dependent diabetes mellitus in Korea. Journal of Korean Medical Science, 16(4), 391-396. DOI: 10.3346/jkms.2001.16.4.391
  35. S. A. Chang et al. (2004). Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism, 53(2), 142-146. DOI: 10.1016/s0026-0495(03)00314-7
  36. S. Funakoshi et al. (2008). Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Research and Clinical Practice, 82(3), 353-358. DOI: 10.1016/j.diabres.2008.09.010
  37. A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza & P. C. Butler. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 52(1), 102-110. DOI: 10.2337/diabetes.52.1.102
  38. M. Sun et al. (2013). Characterization of $\beta$-cell function and insulin resistance in overweight Chinese adolescents with normal glucose tolerance. Experimental and Therapeutic Medicine, 6(2), 547-551. DOI: 10.3892/etm.2013.1164
  39. S. Deng et al. (2004). Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes, 53(3), 624-632. DOI: 10.2337/diabetes.53.3.624
  40. Y. Matsuzawa. (1997). Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes/Metabolism Research and Reviews, 13(1), 3-13. DOI:10.1002/(sici)1099-0895(199703)13:1<3::aid-dmr178>3.0.co;2-n